A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation
- 6 December 2024
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 66 (4) , 713-720
Abstract
Access to allogeneic and autologous hematopoietic stem cell transplantation (SCT) remains inadequate despite its curative potential across hematologic malignancies. In 2015, Hartford HealthCare (HHC) and the Memorial Sloan Kettering Cancer Center (MSK) established the Shared Care Model (SCM) with a primary aim of enhancing SCT access for HHC patients. The SCM comprises several components: an SCT-dedicated nurse-navigator, a health-information exchange for record sharing, telemedicine, and ongoing training of HHC clinicians in transplant patient selection and management. We evaluated the SCM's impact on SCT access across 126 patients with acute leukemia, myelodysplastic syndrome, and multiple myeloma from 2016-2020. The SCM facilitated 34 referrals. Socio-economic status of HHC referrals by Area Deprivation Index was significantly inferior (38 vs. 14, p < 0.001) when compared to 3,108 non-SCM referrals to MSK during the same period. Allogeneic recipients spent 68-247 days away from home, and autologous recipients 15-48, both requiring few subsequent visits to MSK.Keywords
This publication has 19 references indexed in Scilit:
- Barriers to Access to Hematopoietic Cell Transplantation among Patients with Acute Myeloid Leukemia in VirginiaTransplantation and Cellular Therapy, 2021
- Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B‐cell lymphomaCancer, 2021
- Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on AgeTransplantation and Cellular Therapy, 2020
- Caregivers’ Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer CenterTransplantation and Cellular Therapy, 2020
- Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1–Associated Adult T Cell Lymphoma–Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary CenterTransplantation and Cellular Therapy, 2019
- National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care DeliveryTransplantation and Cellular Therapy, 2015
- Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantationBone Marrow Transplantation, 2012
- Costs and Cost-Effectiveness of Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2012
- The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2012
- Disparity in Survival Outcome after Hematopoietic Stem Cell Transplantation for Hematologic Malignancies According to Area of Primary ResidenceTransplantation and Cellular Therapy, 2007